Feedback / Questions
WM-A1-3389 - WMBIO
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT05872867
Mar 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next